Arteris’ (AIP) Buy Rating Reiterated at Rosenblatt Securities

Rosenblatt Securities reissued their buy rating on shares of Arteris (NASDAQ:AIP) in a research note released on Wednesday,Benzinga reports. Rosenblatt Securities currently has a $15.00 price target on the stock.

Separately, Westpark Capital reiterated a “buy” rating and set a $11.00 price target on shares of Arteris in a report on Wednesday, July 31st.

Arteris Trading Down 3.3 %

NASDAQ:AIP opened at $8.31 on Wednesday. Arteris has a 52 week low of $4.27 and a 52 week high of $9.54. The firm has a 50-day moving average price of $7.33 and a two-hundred day moving average price of $7.66. The company has a debt-to-equity ratio of 0.17, a quick ratio of 1.14 and a current ratio of 1.14. The firm has a market cap of $326.23 million, a price-to-earnings ratio of -8.66 and a beta of 1.13.

Insider Activity

In related news, CFO Nicholas B. Hawkins sold 19,299 shares of Arteris stock in a transaction that occurred on Wednesday, November 6th. The shares were sold at an average price of $8.14, for a total value of $157,093.86. Following the sale, the chief financial officer now owns 192,414 shares of the company’s stock, valued at approximately $1,566,249.96. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In other Arteris news, CFO Nicholas B. Hawkins sold 19,299 shares of the firm’s stock in a transaction on Wednesday, November 6th. The stock was sold at an average price of $8.14, for a total value of $157,093.86. Following the completion of the sale, the chief financial officer now directly owns 192,414 shares of the company’s stock, valued at $1,566,249.96. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, COO Laurent R. Moll sold 37,561 shares of the company’s stock in a transaction on Wednesday, September 4th. The shares were sold at an average price of $7.49, for a total value of $281,331.89. Following the transaction, the chief operating officer now directly owns 544,468 shares in the company, valued at $4,078,065.32. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 143,409 shares of company stock valued at $1,059,138 in the last three months. Company insiders own 33.70% of the company’s stock.

Hedge Funds Weigh In On Arteris

Large investors have recently modified their holdings of the business. US Bancorp DE bought a new position in shares of Arteris in the third quarter worth $34,000. Essex Investment Management Co. LLC bought a new position in Arteris in the 3rd quarter worth about $2,504,000. Algert Global LLC purchased a new position in Arteris during the 2nd quarter valued at about $115,000. The Manufacturers Life Insurance Company purchased a new position in Arteris during the 2nd quarter valued at about $86,000. Finally, CloudAlpha Capital Management Limited Hong Kong bought a new stake in shares of Arteris during the second quarter valued at about $554,000. Hedge funds and other institutional investors own 64.36% of the company’s stock.

Arteris Company Profile

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.